Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Study Title
A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus
Teva Identifier
TV-4710/201
ClinicalTrials.gov Identifier
NCT00203151
Study Status
Terminated
Trial Condition(s)
Systemic Lupus Erythematosus
Interventions
Drug: edratide

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 65 Years
Trial Duration
07/01/2005 - 02/01/2007
Phase
Phase 2

Study Type

Interventional